meta_pixel
Tapesearch Logo
Log in
AFP: American Family Physician Podcast

Episode 70 - September 15, 2018 AFP: American Family Physician

AFP: American Family Physician Podcast

American Academy of Family Physicians

Medicine, Americanfamilyphysician, Afppodcast, Familymedicinepodcast, Afp, Clinicalpodcast, Aafp, Health & Fitness, Primarycarepodcast, Medicinepodcast, Aafppodcast

2.4649 Ratings

🗓️ 24 September 2018

⏱️ 21 minutes

🧾️ Download transcript

Summary

Febuxostat (1:30), hemolytic anemia (3:50), STEPS: crisaborole (8:00), screening ECGs (9:40), well-child visits (13:20), and HPV testing (18:00).

Transcript

Click on a timestamp to play from that location

0:00.0

The AFP podcast is supported by the American Academy of Family Physicians and by AAPFP Virtual Care,

0:08.3

powered by Sygnosis, a telemedicine software platform exclusively for AAFP members.

0:14.5

AAFP Virtual Care is designed for clinical efficiency, convenience, and high-quality care

0:20.4

through online patient

0:21.7

interviews and video visits. Learn more at aafp.org slash aafp virtual care. Welcome to the American Family Physician podcast for the September 15th, 2018 issue.

0:50.9

I'm Jake.

0:51.6

I'm Kim, and I'm Jenna.

0:53.3

And we are residents and faculty, mostly residents,

0:56.5

of the University of Arizona College of Medicine Phoenix Family Medicine Residency.

1:01.4

Today on the podcast, we're going to talk about phobuxostat, hemolytic anemia, eukrissa,

1:07.0

screening EKGs, well-child visits, and HPV testing.

1:12.5

The opinions expressed in the podcast are our own and do not represent the opinions of the American Academy of Family Physicians, the editor of American Family Physician or Banner Health.

1:19.6

Do not use this podcast for medical advice. Instead, see your own family doctor for medical care.

1:25.4

We're on a mission to living the best from American Family Physicians. All right.

1:40.5

All right, guys.

1:43.3

First up, we have a poem, Faboxostat.

1:44.1

What do you got, Kim?

1:53.5

This poem asks the clinical question. Do fibuxostat, brand name, euloric, and allopurinol differ with regard to cardiovascular safety?

1:59.3

Kim, these are gout drugs. So why do we care about cardiovascular mortality?

2:01.6

Well, I'm glad you asked, because I actually didn't know this.

2:07.7

It turns out gout is an independent risk factor for cardiovascular disease, and manufacturers have been asked to perform safety trials because of this.

2:11.3

Interesting.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from American Academy of Family Physicians, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of American Academy of Family Physicians and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.